(NEO:Consolidated Issue listed on NASDAQ Capital Market)
Maher Albitar M.D.
Chief Medical Officer and Director of Research & Development, Neogenomics Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 4 different industries.|
As of Fiscal Year 2013
Dr. Maher Albitar, M.D. has been Chief Medical Officer and Director of Research & Development at NeoGenomics Laboratories, Inc. since January 2012. Dr. Albitar has been Chief Medical Officer and Director of Research & Development of Neogenomics Inc. since January 9, 2012. Dr. Albitar served as a Consultant of Health Discovery Corporation since November 15, 2012 and served as its Chief Medical Officer from May 2010 to April 7, 2011. Dr. Albitar has also served as a consultant ...
12701 Commonwealth DrivePhone: 239-768-0600
Fort Myers, Florida 33913
Board Members Memberships*
Damascus Medical School In Damascus Syria
The University of Pennsylvania
|Elazar Rabbani Ph.D.||Co-Founder, Chairman, Chief Executive Officer and Secretary|
Enzo Biochem Inc.
|Raymond C. Kubacki Jr.||Chairman, Chief Executive Officer and President|
|Kenneth A. Berlin||Chief Executive Officer and President|
Rosetta Genomics, Ltd.
|Thomas A. Bologna||Chairman and Chief Executive Officer|
Response Genetics, Inc
|Samuel D. Riccitelli||Chief Executive Officer, President and Director|
Signal Genetics, Inc.
|$469.8K||Compensation as of Fiscal Year 2014.|